Indeed, we observe that FGFR1, 2, and 4 can all interact with TAK1 (Figure 1E), and overactivation of all has been associated with various human cancers, including those of the breast, lung, colon, endometrium, and prostate (reviewed in [10], [31]). This evidence concerns the gene FGFR1 and cancer.